Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
The AD8, a brief eight-question screening tool, does produce false positives—meaning it sometimes suggests cognitive decline when none exists or when decline is not dementia-related. Studies show that roughly 20-30% of people who score positive on the AD8 do not have actual cognitive impairment, particularly in populations with lower education levels, depression, or other medical conditions that can mimic the symptoms the test detects. This happens because the AD8 measures changes in thinking, memory, and function reported by an informant (usually a family member), but those changes can stem from depression, sleep problems, medication side effects, or normal aging rather than neurodegenerative disease.
Understanding when and why false positives occur is crucial for patients and families considering memory concerns. A positive AD8 result is not a diagnosis—it’s a red flag that warrants further evaluation by a healthcare provider, including detailed cognitive testing, medical history review, and sometimes brain imaging. The real risk of false positives is unnecessary alarm and cascading medical workups, but the greater clinical concern is false negatives: the test misses mild cognitive impairment in roughly 10-15% of cases, particularly in people with high education or strong verbal ability who can compensate during screening.
Table of Contents
- What Does a False Positive AD8 Result Actually Mean?
- How Often Do False Positives Happen and Why?
- Clinical Consequences of AD8 False Positives
- Practical Guidance for Families Interpreting AD8 Results
- Who Is Most Likely to Experience False Positives?
- Comparing the AD8 to Other Cognitive Screening Tools
- Future Directions in Cognitive Screening
- Conclusion
- Frequently Asked Questions
What Does a False Positive AD8 Result Actually Mean?
A false positive occurs when the ad8 suggests someone has cognitive impairment, but comprehensive neuropsychological testing or clinical evaluation determines they do not. The AD8 relies on an informant—typically a spouse, adult child, or close caregiver—who reports whether they’ve noticed changes over the past several years in the person’s memory, thinking, or ability to handle finances or medications. If the informant answers “yes” to at least two questions, the screening score is positive. However, the person being screened may feel they’re functioning perfectly well, or their difficulty might stem from a completely different cause. For example, a 68-year-old woman reported by her daughter to be more forgetful about appointments and occasionally repeating stories scores positive on the AD8.
However, a follow-up neuropsychological battery reveals her memory is normal; her reported changes are explained by her starting a new blood pressure medication that causes mental fog and her recently increased work stress. Her doctor adjusts her medication, her focus improves, and her cognitive scores normalize. This is a false positive: the screening suggested impairment that doesn’t actually exist. The distinction matters because false positives drive unnecessary anxiety, additional testing, and sometimes overtreatment. Older adults and their families may internalize a positive screening result as a death sentence for their independence, when in reality a thorough evaluation clears them of any cognitive disorder.
How Often Do False Positives Happen and Why?
Research on the AD8’s accuracy varies depending on the population studied, but meta-analyses suggest sensitivity (ability to catch true cases) of around 75-90%, with specificity (ability to correctly identify those without impairment) of 60-80%. This means that in clinical practice, you can expect a meaningful number of false positives, especially in certain groups. The false positive rate is highest in people with depression, another common condition in older adults; those with fewer years of formal education; and those with sensory impairments like hearing loss that can masquerade as cognitive decline. One limitation of the AD8 is that it doesn’t distinguish between types of cognitive change. A person with major depression can report difficulty concentrating, forgetfulness, and reduced ability to manage finances—all of which trigger a positive AD8—even though their cognitive hardware is intact and cognition fully reverses when depression is treated.
Similarly, sleep apnea, thyroid dysfunction, and nutritional deficiencies can all produce cognitive symptoms that ring alarm bells on the AD8 but are medically reversible. The informant’s own perception and mood also influence false positives. A caregiver who is stressed, has anxiety, or is hyper-vigilant may overestimate changes in the person they’re reporting on. A caregiver in denial may underestimate them, leading to false negatives instead. The AD8 is only as good as the honesty and accuracy of the person filling it out.
Clinical Consequences of AD8 False Positives
When a primary care doctor receives a positive AD8, the appropriate next step is either a brief office-based cognitive assessment (like the Montreal Cognitive Assessment) or referral to neurology or geriatrics for more thorough neuropsychological testing. Many busy primary care practices, however, may refer the patient directly to memory clinics or order expensive neuroimaging, starting a cascade of tests before less invasive assessments have ruled out treatable conditions. A false positive can set patients on a path of repeated scans, specialist visits, and potential overdiagnosis. There is also a psychological impact.
A person who receives a positive screening result, even a false one, often internalizes it as a harbinger of dementia. They may begin to attribute every forgotten name or misplaced key to cognitive decline rather than normal aging. This “nocebo” effect—where the expectation of decline leads to increased anxiety, poorer sleep, and worse cognitive performance on subsequent testing—can actually worsen cognitive function during the evaluation period, perpetuating the false positive finding. Conversely, the clinical consequence of a false negative (missing true impairment) may be more serious long-term. Someone who scores negative on the AD8 but actually has early cognitive decline may delay seeking specialist evaluation and miss the window for early intervention with medications like aducanumab or lecanemab that show benefit in early stages of cognitive decline.
Practical Guidance for Families Interpreting AD8 Results
If a family member receives a positive AD8 score, the immediate action is not to panic but to seek formal cognitive evaluation. Before scheduling expensive testing, families should consider whether recent life changes, mood shifts, or medical changes might explain the reported cognitive changes. Has the person recently started new medications? Experienced a significant loss or life stress? Developed sleep problems? Changed their routine? These contextual details often explain positive screening results and should be discussed with the person’s doctor.
A practical approach is to compare the AD8 result with the person’s actual daily functioning. Can they still manage their finances, take medications independently, prepare meals, and maintain social engagement? If yes, a positive AD8 is less concerning and more likely a false positive, particularly if the cognitive concern is limited to one or two domains like occasional forgetfulness. If there are genuine functional declines—the person can no longer balance a checkbook, repeatedly fails to take medications, or withdraws from hobbies they enjoyed—then further evaluation is warranted regardless of AD8 score, because the test is not a substitute for clinical judgment.
Who Is Most Likely to Experience False Positives?
Certain groups face higher false positive rates on the AD8, and recognizing these patterns helps contextualize results. Older adults with depression score false positives at much higher rates than those without mood disorders, because depression impairs concentration, motivation, and memory in ways that mimic cognitive impairment. Individuals with hearing loss or vision problems may appear less engaged or responsive during informal cognitive assessment, leading informants to attribute this to thinking problems rather than sensory barriers. People with lower educational attainment may score positive on the AD8 at baseline more often, not because they have cognitive decline but because the test has different thresholds of change across education levels.
Non-native English speakers taking the AD8 in English and those with language-based learning disabilities are also at risk for false positives, as are patients with severe anxiety or recent major life transitions. Importantly, the AD8 was developed and validated primarily in educated, white, mostly English-speaking populations, so its accuracy in diverse populations remains uncertain. A critical limitation of the AD8 is that it cannot distinguish between stable lifelong cognitive traits and true decline. A person who has always been forgetful or disorganized may score positive on the AD8 if their informant reports these traits as changes over time, when in fact nothing has changed. This “trait-state” confusion is a structural source of false positives that the test design cannot fully overcome.
Comparing the AD8 to Other Cognitive Screening Tools
The AD8 is one of several informant-based cognitive screening tools available to primary care providers. The Functional Activities Questionnaire (FAQ) focuses heavily on instrumental activities of daily living like paying bills and driving, making it somewhat better at detecting functional decline. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) is longer and sometimes yields different results than the AD8 on the same patient.
The Montreal Cognitive Assessment (MoCA) and Mini-Cog are performance-based tests that the person themselves takes, which avoids some of the informant bias that inflates AD8 false positives but requires more time and cognitive cooperation from the patient. No single screening tool is perfect. The AD8’s strength is brevity and ease of administration in a busy clinical office; its weakness is dependence on informant accuracy and the resulting false positive rate. Combining the AD8 with a brief performance-based test or a functional questionnaire often yields more reliable results than the AD8 alone.
Future Directions in Cognitive Screening
Emerging research is exploring biomarker-based cognitive screening—blood tests that detect Alzheimer’s pathology (phosphorylated tau, beta-amyloid, p-tau217) before symptoms appear or before cognitive decline is evident on behavioral screening. These biomarker tests could theoretically reduce false positives by providing objective evidence of underlying neurodegeneration.
However, they raise their own challenges: detecting Alzheimer’s pathology in the blood does not always predict clinical symptoms, and widespread biomarker screening of asymptomatic older adults raises questions about how to manage preclinical disease. Looking forward, the goal is not necessarily to replace screening tools like the AD8 but to use them as part of a comprehensive, multi-method assessment that includes the person’s own self-report, an informant’s observations, objective cognitive testing, functional assessment, and increasingly, biomarker data when available. Individualized cognitive aging is complex, and no single test can capture it.
Conclusion
False positives on the AD8 occur in roughly 20-30% of screened individuals, particularly among those with depression, lower education, sensory impairments, or medical conditions mimicking cognitive decline. A positive AD8 is a signal to seek further evaluation—not a diagnosis or reason for alarm. The key is understanding what a positive result means in context: it suggests cognitive change worthy of investigation, but that change could stem from depression, medication, thyroid disease, sleep apnea, or simply a hypersensitive observer rather than from neurodegeneration.
The path forward after a positive AD8 is thoughtful evaluation that considers the person’s actual daily functioning, recent medical or life changes, and formal neuropsychological assessment by a qualified specialist. Families should avoid both the extremes of dismissing a positive result and catastrophizing it. Instead, treat it as useful clinical information that warrants investigation—not a verdict, but a prompt for conversation with a healthcare provider about whether genuine cognitive decline is present.
Frequently Asked Questions
Does a positive AD8 mean I have dementia?
No. A positive AD8 means cognitive changes have been observed and warrant further evaluation by a healthcare provider. Many people with positive AD8 scores do not have dementia or any cognitive impairment. They may have depression, medication side effects, or normal aging variations.
What should I do if I score positive on the AD8?
Schedule an appointment with your primary care doctor or a neurologist to discuss the result. Be prepared to describe any recent changes in your health, medications, mood, or life circumstances. Ask whether formal cognitive testing is warranted, and if so, by whom and when.
Is the AD8 test accurate in all age groups?
The AD8 has been studied most extensively in people over 65. Its accuracy in younger people with cognitive concerns or in very elderly populations (85+) is less well established. Its accuracy also varies by education level, language, and presence of depression or other medical conditions.
Can a false positive AD8 harm me?
The main harm of a false positive is unnecessary anxiety and potentially cascading medical testing that may not be needed. Some people begin to view themselves as cognitively impaired after a positive screening, which can negatively affect confidence and mood. However, further evaluation by a qualified clinician can typically resolve the question and distinguish true impairment from false positives.
What if the AD8 is negative but I’m still worried about my memory?
A negative AD8 does not rule out early cognitive impairment, especially if you’re highly educated or have strong verbal skills. If you or a close observer notice genuine functional changes, discuss them with your doctor even if the AD8 was negative. Clinical judgment and functional assessment matter as much as screening scores.
How can I reduce the chance of a false positive AD8?
Ensure your informant knows you well and has observed you over time. Before the test, address any treatable conditions like depression, sleep problems, or medication side effects. Be honest with your informant about whether reported changes are truly new or have always been part of your baseline functioning.
